Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 412

Five stock recoveries not hanging on COVID predictions

Let’s face it. We couldn't predict COVID and we couldn't predict the impact on the economy of the stimulus and which sectors would benefit. We couldn't predict the fact that people would start buying more because they weren't traveling and all the other consequences of the COVID recovery.

What we can do is pick stocks, using a disciplined investment process to find businesses that have sustainable competitive advantages on a three- to five- year view, with strong financials that we believe will preserve investor capital in a crisis like COVID where the market collapses precipitously.

With or without COVID, investors want businesses with predictable earnings and recurring revenues, especially disruptive businesses benefitting from change in the global economy, with a large addressable market.

Here are some examples of what happened during COVID.

Two great Australian companies, ARB and Breville

The first two stocks are companies that we have owned in our portfolios for over 10 years. We believe that over three- to five- years, they will innovate and export their IP from Australia to the world, where they have low market shares relative to their penetration in Australia.

ARB Corporation (ARB) is a 4X4 accessories producer that has spent more than 30 years investing in R&D on its products. It has cash on its balance sheet and a big distribution network in Australia and increasingly, overseas.

Breville (BRG) not only makes toasters and small items but also sells $4,500 coffee makers in many countries around the world. In fact, their sales in the US are 2.5 times the sales in Australia and in Europe, they're 1.5 times. Breville is growing rapidly but they own only a small part of the appliance market globally.

The price charts of the two companies are below.

Source: Factset. Price returns shown. Data 31 December 2019 to 31 May 2021.

Source: Factset. Price returns shown. Data 31 December 2019 to 31 May 2021.

When COVID hit, the market sold ARB as investors thought nobody was fitting accessories to their vehicles. What actually happened - and we couldn't predict this - was that people couldn't go to Bali or Disneyland and they bought second-hand four-wheel-drives because they couldn’t buy new ones. And then they spent $50,000 a pop on 4X4 accessories, and that happened in both Australia and the US generating record earnings for ARB.

Likewise with Breville, as people initially thought stores would close and nobody would replace their home appliances. What actually happened was people stayed at home when the coffee shops shut, or people did not feel comfortable going out, so they bought top-of-the-range coffee makers for their own espresso at home. And they bought rice cookers and bread makers, plus they shopped online in both Australia and the US, either directly or through various other means. The result was worldwide record sales.

Clearly, we couldn't predict what happened. What we did was pick great businesses with a three- to five-year view, and then we bought more as the earnings came through. Many of our peers may have sold out because they thought earnings in these companies would collapse or underperform when stores closed. 

But we didn’t make any recovery prediction. We stuck by our opinion and these companies suddenly became incredibly cheap on a longer-term view of two great Australian companies. The businesses were already growing at double digit, and then COVID supercharged them.

Online travel will also recover

We have two long-term travel holdings in our portfolio because they are global, Australian businesses leveraged to the travel market. Corporate Travel Management (CTD) is a global leader in business travel, having invested in innovative software which is driving efficiencies for its customers globally. It's gaining market share but with many company employees not travelling, the share price of CTD has not recovered to pre-COVID levels, as shown below.

Similarly with Webjet, which is a long way off its high. It is better known for its Business-to-Consumer travel in Australia, where people go to the web portal for tickets. This part of the business is recovering, but it's a digital company. On both companies, we take our three- to five-year view despite the hit from COVID. Webjet still has a way to go because holiday travel has yet to recover, but it is a digital platform delivering travel solutions to companies and to consumers.

Source: Factset. Price returns shown. Data 31 December 2019 to 31 May 2021.

Source: Factset. Price returns shown. Data 31 December 2019 to 31 May 2021.

We don't own Flight Centre because we've taken a view around the lack of a sustainable competitive advantage in its business. It is far less of a digital business. We are concerned about the balance sheet liability associated with its significant store lease footprint that we believe will be challenged in the future.

IDP Education as a global provider

IDP Education delivers English language testing globally, especially for students studying at English-speaking universities in the UK and North America. It was adversely impacted by COVID initially, but what actually panned out was that in the UK, the market was open to international students to the detriment of Australia. North America was also open and IDP was able to sell more of its digitally-enabled market-leading university placement products. COVID helped in bringing forward its digital business.

Source: Factset. Price returns shown. Data 31 December 2019 to 31 May 2021.

Australia is still not open to international students but IDP returned to pre COVID price levels quickly. We think this is a great business that is disrupting an industry using its English language client base to start a student placement programme, which is gaining share globally.

What about the higher income from banks?

We are often asked questions on banks and bank yields. The following chart shows that despite the heavy position of high-yielding banks in 50 Leaders Index, the small cap and mid cap indexes have done better over any of time periods in the chart. These total returns include the attractive yields that the banks deliver.

The key takeaway is that if an investor can identify businesses that are innovative and growing and can protect capital due to privileged assets with long-term contracted revenue, they should deliver better returns over time.

Bank yields or innovation and growth? Small and mid caps taking the lead.

Source: Bloomberg. Total returns shown to 30 April 2021.

Where are we now in the cycle and outlook for small and mid cap companies?

The answer is very stock specific. We have recently seen some major falls in overpriced companies where investors did not understand the risks. While the Small Cap Index is up about 27% in the year to end-May 2021 and our portfolio has outperformed over the same period, it’s unlikely we will see such results again. There are strong, disruptive businesses but there are also pockets of small caps that are overpriced, especially when they don't have a strong business producing free cash flow and funding their own growth. But businesses with sustainable competitive advantages, strong financials and predictable earnings should continue to do well.

 

Dawn Kanelleas is Head of Australian Small and Mid-Cap Companies at First Sentier Investors, a sponsor of Firstlinks. This article is for general information only and is not a substitute for tailored financial advice. Any stock mentioned does not constitute any offer or inducement to enter into any investment activity.

 

For more articles and papers from First Sentier Investors, please click here.

 

4 Comments
Scott
June 16, 2021

This article shows how hard it is to be a successful stock picker over time.
I bought the small companies VSO ETF last year and so far its returning 61%.

Below is some great wisdom from Jack Bogle: 10 Mistakes Every Investor Makes
https://www.youtube.com/watch?v=ukJ77ycGNC8

Below is also some great wisdom from Stanley Druckenmiller who talks about what makes a great investor.
https://www.youtube.com/watch?v=uTeFU1qivbs.
He makes a very clear point on why the likes of Warren Buffett, Carl Ikahn and George Souris do so well, is because "they make very big high conviction investments into a small number of stocks/assets."
This goes against the what is normally taught in business school about diversification.

CC
July 25, 2021

Scott, plenty of small company fund managers outperform the VSO or XSO small cap index in Australia.
I own several of them.
Small caps and microcaps is an area of the market where skilled fund managers are far more likely to outperform than in larger caps. There are plenty of poor quality small cap companies in the index that are best avoided.

Frankie
June 16, 2021

I like the idea that smaller companies are covered by fewer analysts and therefore gems can be uncovered, and often have better growth paths because they are still small, but it worries me that they might fall more in a declining market as people rush for safety.

Steve Mattani
June 16, 2021

While Webjet will in all probability return to pre Covid profitability, it's return metrics will be far less attractive due to the massive increase in equity issued over the last 15 months. Headline profits will rise on re-opening but I anticipate pre-viral ROE will be impaired for many years to come based on historicals.

 

Leave a Comment:

RELATED ARTICLES

The companies well placed to weather an economic storm

Three new lessons about listed companies during COVID-19

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.